The involvement of NMDA receptor/NO/cGMP pathway in the antidepressant like effects of baclofen in mouse force swimming test. (26th January 2016)

• Record Type: Journal Article
• Authors: Khan, Muhammad Imran; Ostadhadi, Sattar; Zolfaghari, Samira; Ejtemaei Mehr, Shahram; Hassanzadeh, Gholamreza; Dehpour, Ahmad-Reza
• Is Part Of: Neuroscience letters. Volume 612(2016)
• Page Start: 52
• Page End: 61
• Publication Date: 2016-01-26
• Subjects: Baclofen -- N-methyl-d-aspartate (NMDA) -- Nitric oxide -- Depression -- Forced swimming test -- Mice; Neurology -- Periodicals; Neurology -- Periodicals; Research -- Periodicals; Neurologie -- Périodiques; Neuroanatomie -- Périodiques; Neuropharmacologie -- Périodiques; Neurophysiologie -- Périodiques; Neurology; Periodicals; Electronic journals; 617.48
• DOI: 10.1016/j.neulet.2015.12.006
• Languages: English
• ISSNs: 0304-3940

Abstract

Graphical abstract: Highlights: Baclofen has an anti-depressant like effect in forced swimming test. This effect increased by inhibition of nitric oxide production. This effect increased by NMDA receptor antagonist. This effect decreased by PDE5 inhibition. The antidepressant-like action of baclofen mediated by NMDA receptors and NO-GMP pathway in forced swimming test Abstract: In the current study, the involvement of N -methyl-d -aspartate receptor (NMDAR) and nitric oxide (NO)/cyclic guanosine monophosphate (cGMP) system in the antidepressant-like effects of baclofen was evaluated by using animal model in forced swimming test. Followed by an open field test for the evaluation of locomotor activity, the immobility time for mice in force swimming test was recorded. Only the last four min was analyzed. Administration of Baclofen (0.5 and 1 mg/kg, i.p.) reduced the immobility interval in the FST. Prior administration ofl -arginine (750 mg/kg, i.p., ) a nitric oxide synthase substrate or sildenafil (5 mg/kg, i.p.) a phosphodiesterase 5 into mice suppressed the antidepressant-like activity of baclofen (1 mg/kg, i.p.).Co-treatment of 7-nitroindazole (50 mg/kg, i.p., ) an inhibitor of neuronal nitric oxide synthase, L -NAME (10 mg/kg, i.p., ) a non-specific inhibitor of nitric oxide synthase or MK-801 (0.05 mg/kg, i.p.) an NMDA receptor antagonist with subeffective dose of baclofen (0.1 mg/kg, i.p.), reduced the immobility time in the FST as compared to the drugs when used alone. Co-administrated of lower doses of MK-801 (0.01 mg/kg) orl -NAME (1 mg/kg) failed to effect immobility time however, simultaneous administration of these two agents in same dose with subeffective dose of baclofen (0.1 mg/kg, i.p.), minimized the immobility time in the FST. Thus, our results support the role of NMDA receptors andl -arginine-NO-GMP pathway in the antidepressant-like action of baclofen.